Skip to main content
. 2019 Dec 10;21(1):e9. doi: 10.4142/jvs.2020.21.e9

Table 1. Different treatments from day 0 to day 4 in 6 different groups.

Group 0–2 days 3–4 days
F Null FGF2
FB Null FGF2+BMP4
BFB BMP4 FGF2+BMP4
CF CHIR99021 FGF2
CFB CHIR99021 FGF2+BMP4
CBFB CHIR99021+BMP4 FGF2+BMP4

BMP4, bone morphogenetic protein 4; CHIR99021, combination of GSK3β inhibitor; FGF2, fibroblast growth factor 2.